Altered Thyroid Function Tests Observed in Hypophosphatasia Patients Treated with Asfotase Alfa
Background. Asfotase alfa is the only approved treatment that can normalize mineralization in patients with hypophosphatasia (HPP). Its interference in alkaline phosphatase (ALP) dependent immunoassays has been reported. Objective. To describe thyroid function tests interfered with by asfotase alfa...
Saved in:
Main Authors: | Hajime Kato, Naoko Hidaka, Minae Koga, Yuka Kinoshita, Masaomi Nangaku, Noriko Makita, Nobuaki Ito |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-01-01
|
Series: | International Journal of Endocrinology |
Online Access: | http://dx.doi.org/10.1155/2021/5492267 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
FGF23-related hypophosphatemia in a patient with small cell lung cancer: a case report and literature review
by: Hajime Kato, et al.
Published: (2023-10-01) -
Adult hypophosphatasia presenting with recurrent acute joint pain
by: Hayao Yoshida, et al.
Published: (2025-01-01) -
An Unusual Stress Fracture in an Archer with Hypophosphatasia
by: Umut Yavuz, et al.
Published: (2013-01-01) -
A Case of Hypophosphatasia Started Enzyme Replacement Therapy Since Babyhood Stage
by: Tatsuya Akitomo, et al.
Published: (2025-01-01) -
Atypical Femoral Fracture in Hypophosphatasia: A Systematic Review
by: Nipith Charoenngam, et al.
Published: (2023-01-01)